Cutaneous leukocytoclastic vasculitis secondary to cabozantinib therapy for renal cell carcinoma. Coltart GS, Sutton JE, Roche HJ, Sommerlad MP, et al. Clin Exp Dermatol 2020 Dec 17. doi: 10.1111/ced.14541.

Read + Share

Amedeo Smart

Independent Medical Education

Coltart GS, Sutton JE, Roche HJ, Sommerlad MP, et al. Cutaneous leukocytoclastic vasculitis secondary to cabozantinib therapy for renal cell carcinoma. Clin Exp Dermatol 2020 Dec 17. doi: 10.1111/ced.14541.
PMID: 33332666